2012-2013 Executive Board
According to the ASC Bylaws:
The general managment of the American Society of Cytopathology, including approval of the annual budget, shall be vested in the Executive Board. It shall regularly perform the ordinary duties of a board of directors to appoint any Committee it may deem necessary and to delegate whatever powers necessary to such Committees.
Executive Board Members are elected to serve a four-year term on the Board. Board Members are expected to regularly attend Board meetings, to exercise the diligence, review reports and issues with extreme care and question policy and procedures as though they were owners of the corporation.
Officers:
|
|
President: Andrew A. Renshaw, MD Baptist Hospital of Miami Miami, FL |
|
|
President-Elect:
Ritu Nayar, MD |
|
|
Vice President:
Michael R. Henry, MD |
|
|
Secretary-Treasurer: |
Executive Board Members:
|
|
Joel S. Bentz, MD Laboratory Medicine Consultants, Ltd. Las Vegas, NV |
|
|
Jill L. Caudill, MEd, SCT(ASCP)CM Mayo School of Health-Related Sciences Rochester, MN |
|
|
David F. Chhieng, MD |
|
|
Tarik Elsheikh, MD Cleveland Clinic Foundation Cleveland, Ohio |
|
|
Jeffrey F. Krane, MD Brigham & Women's Hospital Boston, MA |
|
|
Kalyani Naik, MS, SCT(ASCP) University of Michigan Hospital Ann Arbor, Michigan |
|
|
Donna K. Russell, MS, CT(ASCP)HT University of Rochester Medical Center Rochester, NY |
|
|
Lynnette C. Savaloja, SCT(ASCP) Regions Hospital St. Paul, MD |
|
|
Patricia Wasserman. MD Columbia University Medical Center New York, New York |
|
|
Amy Wendel Spiczka, MS, SCT, MP, HTL(ASCP)CM |
|
|
Rosemary H. Tambouret, MD Masachusetts General Hospital Boston, MA |
|
|
Philip T. Valente, MD University of Texas Health Science Center San Antonio, TX |
|
|
Eva M. Wojcik, MD, MIAC |
|
|
Past President: Lydia P. Howell University of California Davis Medical Center Sacramento, California |

